Ayurvedic Diet in Myxedema
AYUS-MYX
Ayurvedic Diet as a Supplement to Levothyroxine Treatment of Myxedema
1 other identifier
interventional
88
1 country
2
Brief Summary
Primary hypothyroidism is diagnosed by elevated thyroid stimulating hormone (TSH) level and a reduced thyroxine (T4) level in plasma. Some of the most common symptoms of hypothyroidism are fatigue, weight gain and reduced cognition and is associated with reduced quality of life and increased days of sick leave. Levothyroxine, a synthetic form of T4, is clinically recommended as first-line treatment for hypothyroidism. When normalizing TSH/T4 with levothyroxine, the prevalence of persistent symptoms is present in 15% of patients. The composition of our gut bacteria, the microbiome, plays a significant role for a healthy thyroid gland and metabolism and is influenced by our diet. The Indian medical system, Ayurveda, is based on generations of experience and knowledge in disease prevention and treatment, including various diet plans, exercise and lifestyles that are put into context for physical and mental health. Ayurveda works with four different types of digestion and is based on a vegetarian diet. The purpose of this study is to investigate the effect of an Ayurvedic diet plan, as a supplement to medical treatment, among people with hypothyroidism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 15, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
January 7, 2026
December 1, 2025
2.2 years
December 15, 2025
December 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
digestion
change in digestion measured by self-reported questionnaire
8 weeks
Secondary Outcomes (1)
symptoms of hypothyroidis
8 weeks
Study Arms (2)
habitual diet
OTHERcontinuation of habitual diet
ayurvedic diet
EXPERIMENTALplant based ayurvedic diet
Interventions
Guidance in implementation of a diet adapted to Vishamagni; which foods and flavors are appropriate to consume, intake of oils, eating patterns, herbal supplements and guidance on which foods and flavors are inappropriate to consume. General Ayurvedic dietary advice for vishamagni: Regular meals; 3 main meals daily at approximately the same time. Consume foods with the Ayurvedic taste nuances: sweet, sour and salty. Primarily consume hot and prepared meals. Eat lactovegetarian. Avoid spicy, bitter and astringent foods. Avoid meat, raw vegetables (all vegetables must be cooked), dry and crunchy foods such as crackers, dried fruit, rice crackers and muesli, and avoid ice cold foods and drinks. One Ayurvedic herbal supplement MA505 (Triphala), with fruits and spices intended to balance the digestive type Vishamagni
Eligibility Criteria
You may qualify if:
- diagnosed with primary hypothyroidism
- primary digestive type Vishamagni
- under medical treatment for hypothyroidism
- unchanged medication for the past 6 months
You may not qualify if:
- previous Ayurvedic treatment
- prescription drugs other than medication for hypothyroidism
- pregnancy
- lactating women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Nutrition, Exercise and Sports
Copenhagen, Frederiksberg, 1954, Denmark
Ayuvedic Clinic, Sorø
Sorø, 4180, Denmark
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jens Rikardt Andersen, MD, MPA
University of Copenhagen
- PRINCIPAL INVESTIGATOR
Mette Westerholt, MSc
AYUS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2025
First Posted
January 7, 2026
Study Start
October 1, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2029
Last Updated
January 7, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share